The South Dakota House of Representatives Health and Human Services Committee approved a Senate bill that would add post-traumatic stress disorder (PTSD) to the list of ailments for which providers could prescribe medical marijuana (MMJ).
What’s In It?
Bill 1, which passed in an 8 to 5 vote, would allow the state Department of Health to remove a requirement over how the department chooses whether a medical condition qualifies for treatment with cannabis. Additionally, it would allow the legislature to decide on diagnoses of MMJ use, per a local news outlet. The measure was sent to the House for final consideration.
If the legislation is enacted, it would amend the law to include additional debilitating medical conditions for medical cannabis use, such as diagnosis of cancer and seizure disorders, to name a few.
Senator Erin Tobin (R), who is also a nurse practitioner, recently said the legislation would help guide healthcare workers to continue educating themselves on medical cannabis. “SB 1 [that is on its way to the House] really helps clear that up, because we’re really good at diagnosing people (...) Once we have a diagnosis, I think it will make it easier, then, to say, ‘yes, you need a medical marijuana card."
The interim cannabis study group, that proposed the legislation, "did not look at the science enough to consider cannabis as a treatment for PTSD," said Rep. Fred Deutsch (R).
In related news, two measures (GOP-led HB 1172 and 1129) seeking to strike down South Dakota's 'pop-up clinics' for medicinal cannabis were recently killed by members of the Senate committee. Sponsored by Rep. Deutsch, the two bills would have banned ads for medical cannabis that would guarantee a card and telehealth appointments or financial incentives to make an appointment.
Benzinga's Cannabis Capital Conference Is Back
The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out. Secure your tickets now. Prices will go up soon.
Image Credits: Cannafornia On Pexels By El Planteo
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.